SCHEMBL6133622

SCHEMBL6133622

COCCCCCOc1ccc(CCO)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 3/20 0.53
MEN1 O00255 3/20 0.53
KMT2A Q03164 3/20 0.53
LMNA P02545 3/20 0.53
USP2 O75604 1/20 0.53
ALDH1A1 P00352 1/20 0.53
CYP3A4 P08684 1/20 0.53
MAPK1 P28482 1/20 0.53
CASP1 P29466 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
SLCO1B3 Q9NPD5 1/20 0.53
SLCO1B1 Q9Y6L6 1/20 0.53
GAA P10253 2/20 0.44
NPC1 O15118 2/20 0.44
TP53 P04637 1/20 0.44
RAB9A P51151 1/20 0.44
NR5A1 Q13285 1/20 0.44
FFAR1 O14842 1/20 0.44
LTA4H P09960 1/20 0.44
EPHX2 P34913 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8498228 0.86 MEN1 (0.69) HRH3MEN1KMT2ALMNAUSP2
SCHEMBL27805470 0.86 MEN1 (0.69) HRH3MEN1KMT2ALMNAUSP2
SCHEMBL8500363 0.86 MEN1 (0.69) HRH3MEN1KMT2ALMNAUSP2
SCHEMBL12559687 0.86 MEN1 (0.69) HRH3MEN1KMT2ALMNAUSP2
SCHEMBL7623214 0.86 MEN1 (0.69) HRH3MEN1KMT2ALMNAUSP2
SCHEMBL10427155 0.86 MEN1 (0.69) HRH3MEN1KMT2ALMNAUSP2
SCHEMBL1667156 0.86 MEN1 (0.69) HRH3MEN1KMT2ALMNAUSP2
SCHEMBL13096748 0.86 LMNA (0.49) HRH3MEN1KMT2ALMNAUSP2
SCHEMBL14231801 0.85 HRH3 (0.50) HRH3MEN1KMT2ALMNAUSP2
SCHEMBL12198485 0.85 ALDH1A1 (0.54) HRH3MEN1KMT2ALMNAUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050261177-A1 Compound ASTELLAS PHARMA INC. (JP) 2005-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050261177-A1 Compound MANBA, MAN2B1, MAN2A1 HRH3 1440/4885MEN1 880/4885KMT2A 4492/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.